| Name | Title | Contact Details |
|---|---|---|
Mark Finkle |
VP of Engineering (Productivity & Developer Program) | Profile |
For more than 130 years, Boehringer Ingelheim has been committed to the research, development, and manufacturing of new medications with high therapeutic value for people and animals. As a family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in research and development. We are proud of addressing some of the most challenging healthcare issues. Our vision – value through innovation – has always characterized our collaborative work, and is for us simultaneously a fundamental requirement and a driving force. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally through 145 affiliates and a total of some 47,500 employees.
Seabury is an active life care community in Bloomfield, CT that offers independent living, assisted living, memory support, skilled nursing, and outpatient rehabilitation services.
Millennium Laboratories, a leader in the science of toxicology and pharmacogenetics, is transforming the way health care providers improve clinical outcomes. Millennium helps practitioners provide personalized care to patients in need through its patient-centered research and education initiatives and its ability to respond to evolving health care challenges with advanced technologies.
BlackSea Technologies is a naval technology firm that enables new asymmetric strategies so U.S. Naval and military forces can prevail over the next several decades in multi-dimensional conflicts.
Trusted by more than 50,000 customers, Briggs has been helping health care providers improve clinical and financial performance through a wide array of products for more than 60 years.